ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$195.02+3.62 (+1.89%)
Close on Nov 17, 2026Market cap $14.93BP/E 33.6Yield –
ICON operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ICON's operating cash flow for the twelve months ending Sep 30, 2026 was $1.03B, down 9.9% year over year. For fiscal 2025 it was $1.04B, down 19.5% from the year before. Over ten years it grew 14.0% a year on average. The highest annual figure on record is $1.29B in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | -19.5% |
| FY2024 | Dec 31, 2024 | $1.29B | +10.8% |
| FY2023 | Dec 31, 2023 | $1.16B | +106.1% |
| FY2022 | Dec 31, 2022 | $563.32M | -32.1% |
| FY2021 | Dec 31, 2021 | $829.14M | +46.0% |
| FY2020 | Dec 31, 2020 | $568.04M | +37.7% |
| FY2019 | Dec 31, 2019 | $412.54M | +53.6% |
| FY2018 | Dec 31, 2018 | $268.64M | -29.9% |
| FY2017 | Dec 31, 2017 | $383.08M | +47.8% |
| FY2016 | Dec 31, 2016 | $259.20M | -7.1% |
| FY2015 | Dec 31, 2015 | $279.07M | +65.1% |
| FY2014 | Dec 31, 2014 | $169.04M | -23.6% |
| FY2013 | Dec 31, 2013 | $221.23M | +95.0% |
| FY2012 | Dec 31, 2012 | $113.43M | +461.8% |
| FY2011 | Dec 31, 2011 | $20.19M | -76.9% |
| FY2010 | Dec 31, 2010 | $87.43M | -65.7% |
| FY2009 | Dec 31, 2009 | $255.07M | +213.8% |
| FY2008 | Dec 31, 2008 | $81.28M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $345.14M | -11.0% |
| Q2 FY2026 | Jun 30, 2026 | $281.27M | +92.4% |
| Q1 FY2026 | Mar 31, 2026 | $167.01M | -37.7% |
| Q4 FY2025 | Dec 31, 2025 | $234.16M | -30.8% |
| Q3 FY2025 | Sep 30, 2025 | $387.60M | -3.7% |
| Q2 FY2025 | Jun 30, 2025 | $146.20M | -33.1% |
| Q1 FY2025 | Mar 31, 2025 | $268.24M | -18.0% |
| Q4 FY2024 | Dec 31, 2024 | $338.31M | -23.1% |
| Q3 FY2024 | Sep 30, 2024 | $402.67M | +17.9% |
| Q2 FY2024 | Jun 30, 2024 | $218.59M | +7.2% |
| Q1 FY2024 | Mar 31, 2024 | $327.08M | +86.4% |
| Q4 FY2023 | Dec 31, 2023 | $440.13M | – |
| Q3 FY2023 | Sep 30, 2023 | $341.52M | +59.8% |
| Q2 FY2023 | Jun 30, 2023 | $203.88M | +12.0% |
| Q1 FY2023 | Mar 31, 2023 | $175.50M | -22.7% |
| Q4 FY2022 | Dec 31, 2022 | -$59.43M | -120.5% |
| Q3 FY2022 | Sep 30, 2022 | $213.78M | -28.5% |
| Q2 FY2022 | Jun 30, 2022 | $182.05M | +41.7% |
| Q1 FY2022 | Mar 31, 2022 | $226.92M | +102.7% |
| Q4 FY2021 | Dec 31, 2021 | $289.82M | +48.3% |
| Q3 FY2021 | Sep 30, 2021 | $298.97M | +167.0% |
| Q2 FY2021 | Jun 30, 2021 | $128.43M | +8.9% |
| Q1 FY2021 | Mar 31, 2021 | $111.92M | -21.6% |
| Q4 FY2020 | Dec 31, 2020 | $195.42M | +45.4% |
| Q3 FY2020 | Sep 30, 2020 | $111.97M | -30.3% |
| Q2 FY2020 | Jun 30, 2020 | $117.89M | +418.5% |
| Q1 FY2020 | Mar 31, 2020 | $142.76M | +50.9% |
| Q4 FY2019 | Dec 31, 2019 | $134.45M | +120.9% |
| Q3 FY2019 | Sep 30, 2019 | $160.73M | +25.5% |
| Q2 FY2019 | Jun 30, 2019 | $22.74M | -42.0% |
| Q1 FY2019 | Mar 31, 2019 | $94.63M | +133.8% |
| Q4 FY2018 | Dec 31, 2018 | $60.86M | -42.5% |
| Q3 FY2018 | Sep 30, 2018 | $128.11M | +17.8% |
| Q2 FY2018 | Jun 30, 2018 | $39.20M | +331.2% |
| Q1 FY2018 | Mar 31, 2018 | $40.47M | -74.6% |
| Q4 FY2017 | Dec 31, 2017 | $105.90M | -18.6% |
| Q3 FY2017 | Sep 30, 2017 | $108.77M | – |
| Q2 FY2017 | Jun 30, 2017 | $9.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $159.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $130.17M | – |
See a number that looks wrong?